Use of Sugammadex in Myasthenia Gravis and Becker Muscular Dystrophy: Four Cases

Journal Title: Journal of Neurological Sciences-Turkish - Year 2012, Vol 29, Issue 4

Abstract

Myasthenia gravis is an antibody-mediated autoimmune disease targeting nicotinic acid acetylcholine receptors in neuromuscular junctions. In myasthenia gravis, the number of nicotinic acid acetylcholine receptors is significantly reduced. This condition leads to muscular weakness and deserves special attention in terms of respiratory muscles. Becker muscular dystrophy is an X-linked recessive inherited disorder characterized by slowly progressive muscle weakness of the legs and pelvis. Sugammadex is a hydrophilic cyclodextrin molecule that has a lipophilic nucleus. It is an innovative molecule which terminates the effects of steroidal neuromuscular blocking agents via encapsulation. This is a report of the use of sugammadex in patients with MG and Becker muscular dystrophy. Three patients with myasthenia gravis; 55, 45 and 2.5 year-old; were enrolled the surgery under general anesthesia for the disc hernia repair, abdominal hysterectomy, and correcting of cataract, respectively. Additionally, a five-year-old patient with Becker muscular dystrophy was scheduled for circumcision and orchiopexy under general anesthesia. In all patients, rocuronium as a muscle relaxant and sugammadex for the reverse of rocuronium were administered. Tracheal extubation was achieved in all patients at the end of operations without complications. The use of a combination of rocuronium-sugammadex seems safe in muscle diseases without the development of any possible complications.

Authors and Affiliations

Yasemin USTUN, Binnur SARIHASAN, Ismail KOCAMANOGLU, Seda YEGIN, Hatice AZAR

Keywords

Related Articles

A Fatal Hypermetabolic Syndrome: Acute Dopamine Depletion Syndrome

Objective: Neuroleptic malignant syndrome (NMS) is a rare and potentially lethal hypermethabolic disorder associated with the use of antipsychotic medications. A related syndrome “malignant syndrome” occurs in Parkinson’...

Rhombencephalosynapsis: A Rare Cerebellar Malformation

Background: Rhombencephalosynapsis is characterized by agenesis/hypogenesis of the cerebellar vermis along with the fusion of the cerebellar hemispheres in the midline. There are less than 50 cases in the literature, and...

Response to Levetiracetam in a Patient with Posthypoxic Action Myoclonus

Posthypoxic action myoclonus (PAM) can be developed in patients who survived an hypoxic brain injury and is resistant to pharmacological therapy. The patient presented here developed PAM with very serious myoclonic jerks...

[ Abstract ] [ Full Text ] [ PDF ] <br /> Lenalidomide Etkisinin Glioblastoma Hücreleri Üzerinde In Vıtro Koşullarda Değerlendirilmesi <br />

Amaç: Kemoterapide kullanılan ilaçlardan biri olan Thalidomide analogu Lenalidomide’in insan glioblastoma multiforme (GBM) hücreleri üzerinde pro-apoptotik, çoğalmayı azaltıcı ve radyasyona karşı duyarlılığı artırıcı etk...

Total Sialik Asit Düzeyi Strok için Bir Marker Olabilir Mi?

Amaç: Bu çalışmanın amacı; stroklu hastalarda, total serum sialik asit düzeylerindeki değişiklikleri değerlendirmektir. Materyal ve Metod: Bu çalışmaya, akut iskemik serebrovasküler hastalığı olan 62’si kadın, 54’ü erke...

Download PDF file
  • EP ID EP93047
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Yasemin USTUN, Binnur SARIHASAN, Ismail KOCAMANOGLU, Seda YEGIN, Hatice AZAR (2012). Use of Sugammadex in Myasthenia Gravis and Becker Muscular Dystrophy: Four Cases. Journal of Neurological Sciences-Turkish, 29(4), 826-831. https://europub.co.uk./articles/-A-93047